Kim K - Search Results

1

The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.

Choi E, Kim Y, Kim K. Choi E, et al. Among authors: kim y, kim k. Yonsei Med J. 2006 Feb 28;47(1):55-62. doi: 10.3349/ymj.2006.47.1.55. Yonsei Med J. 2006. PMID: 16502485 Free PMC article.

2

Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8.

Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K. Shin S, et al. Among authors: kim w, kim k. EMBO J. 2005 Oct 19;24(20):3532-42. doi: 10.1038/sj.emboj.7600827. Epub 2005 Sep 29. EMBO J. 2005. PMID: 16193064 Free PMC article.

3

Neobavaisoflavone sensitizes apoptosis via the inhibition of metastasis in TRAIL-resistant human glioma U373MG cells.

Kim YJ, Choi WI, Ko H, So Y, Kang KS, Kim I, Kim K, Yoon HG, Kim TJ, Choi KC. Kim YJ, et al. Among authors: kim tj, kim i, kim k. Life Sci. 2014 Jan 30;95(2):101-7. doi: 10.1016/j.lfs.2013.10.035. Epub 2013 Nov 11. Life Sci. 2014. PMID: 24231449

4

Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.

Kim HR, Park HJ, Park JH, Kim SJ, Kim K, Kim J. Kim HR, et al. Among authors: kim sj, kim j, kim k. Cancer Immunol Immunother. 2004 May;53(5):461-70. doi: 10.1007/s00262-003-0461-0. Epub 2003 Nov 28. Cancer Immunol Immunother. 2004. PMID: 14648068 Free PMC article.

5

Silencing Bcl-X(L) in cancer therapy.

Kim K. Kim K. Cancer Biol Ther. 2005 Apr;4(4):398-9. doi: 10.4161/cbt.4.4.1761. Epub 2005 Apr 27. Cancer Biol Ther. 2005. PMID: 15908790 Free article. No abstract available.

6

Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.

Shin EC, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong SS, Park JH. Shin EC, et al. Among authors: kim h, kim ch, kim sj, kim k. Exp Mol Med. 2002 May 31;34(2):114-22. doi: 10.1038/emm.2002.17. Exp Mol Med. 2002. PMID: 12085986

7

Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells.

Ko H, Kim S, Jin CH, Lee E, Ham S, Yook JI, Kim K. Ko H, et al. Among authors: kim s, kim k. Mol Cancer Res. 2012 Aug;10(8):1032-8. doi: 10.1158/1541-7786.MCR-12-0261. Epub 2012 Jul 5. Mol Cancer Res. 2012. PMID: 22767590

8

Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner.

Yoo JY, Choi HK, Choi KC, Park SY, Ota I, Yook JI, Lee YH, Kim K, Yoon HG. Yoo JY, et al. Among authors: kim k. Mol Biol Cell. 2012 Aug;23(15):2943-54. doi: 10.1091/mbc.E11-11-0947. Epub 2012 Jun 6. Mol Biol Cell. 2012. PMID: 22675025 Free PMC article.

9

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

Kim E, Jung Y, Choi H, Yang J, Suh JS, Huh YM, Kim K, Haam S. Kim E, et al. Among authors: kim k. Biomaterials. 2010 Jun;31(16):4592-9. doi: 10.1016/j.biomaterials.2010.02.030. Epub 2010 Mar 4. Biomaterials. 2010. PMID: 20206379

10

Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.

Jin CH, Jun KY, Lee E, Kim S, Kwon Y, Kim K, Na Y. Jin CH, et al. Among authors: kim s, kim k. Bioorg Med Chem. 2014 Sep 1;22(17):4553-65. doi: 10.1016/j.bmc.2014.07.037. Epub 2014 Jul 30. Bioorg Med Chem. 2014. PMID: 25131958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,690 results

Search Page

Filters